To comply with new state regulations in Massachusetts, Tufts Health Plan is expanding coverage for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndromes (PANS) treatments including, but not limited to, the use of intravenous immunoglobulin therapy. Effective upon renewal, starting on January 1, 2022.
Because when employees are healthy and happy, their employer benefits too—from better workplace morale, increased productivity, and controlled costs.